Browse Title Index


 
Issue Title
 
Vol 23, No 6 (2016) Adjuvant systemic chemotherapy for stages II and III colon cancer after complete resection: a clinical practice guideline Abstract   PDF   HTML
B.M. Meyers, R. Cosby, F. Quereshy, D. Jonker
 
Vol 26 (2019): Advances in Colorectal Cancer: Translating Best Evidence to Practice Adjuvant therapy for stages II and III colon cancer: risk stratification, treatment duration, and future directions Abstract   PDF   HTML
U. Bender, Y.S. Rho, I. Barrera, S. Aghajanyan, J. Acoba, P. Kavan
 
Vol 13, No 1 (2006) Adjuvant trastuzumab: progress, controversies, and the steps ahead Details   PDF
John Mackey, Anil A Joy
 
Vol 25, No 6 (2018) Adjuvant treatment in older patients with rectal cancer: a population-based review Abstract   PDF   HTML
S. L. Liu, P. O’Brien, Y. Zhao, W. M. Hopman, N. Lamond, R. Ramjeesingh
 
Vol 23, No 3 (2016) Adolescent and young adult cancer: principles of care Abstract   PDF   HTML
R. Ramphal, S. Aubin, P. Czaykowski, S. De Pauw, A. Johnson, S. McKillop, D. Szwajcer, K. Wilkins, P. Rogers
 
Vol 26, No 1 (2019) Adopting patient-centred tools in cancer care: role of evidence and other factors Abstract   PDF   HTML
A. Glenn, R. Urquhart
 
Vol 24, No 4 (2017) Adrenocortical carcinoma: patterns of care and role of adjuvant radiation therapy— a population-based study and review of the literature Abstract   PDF   HTML
S. Atallah, H. Al-Assaf, Y. Xu, S. El-Sayed
 
Vol 24, No 6 (2017) Adult chronic myelomonocytic leukemia with trisomy 11: a case report Abstract   PDF   HTML
S.H. Yoo, J. Lim, J.M. Byun, J.H. Park, K.H. Kim, I.S. Choi
 
Vol 23, No 5 (2016) Adult-onset Kaposiform hemangioendothelioma of the tongue: case report and review of the literature Abstract   PDF   HTML
P. Vashi, E. Abboud, C. Bier-Laning, D. Gupta
 
Vol 22, No 4 (2015) Advance Care Planning: identifying system-specific barriers and facilitators Abstract   PDF   HTML
N.A. Hagen, J. Howlett, N.C. Sharma, P. Biondo, J. Holroyd-Leduc, K. Fassbender, J. Simon
 
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Advanced typical and atypical carcinoid tumours of the lung: management recommendations Abstract   PDF   HTML
B. Melosky
 
Vol 19, No 2 (2012) Advances in the management of metastatic breast cancer: options beyond first-line chemotherapy Abstract   PDF   HTML
J.P.M. Ayoub, S. Verma, S. Verma
 
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Advances in the systemic treatment of triple-negative breast cancer Abstract   PDF   HTML
J.M. Lebert, R. Lester, E. Powell, M. Seal, J. McCarthy
 
Vol 20, No 1 (2013) Advantages of exercise in breast cancer patients and survivors in addition to its mitigating effect on chest wall pain Details   PDF   HTML
S. Kapoor
 
Vol 17 (2010): Optimal management of metastatic colorectal cancer with the anti-EGFR monoclonal antibodies Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer Abstract   PDF
M. Fakih, M. Vincent
 
Vol 25, No 5 (2018) Afatinib in advanced pretreated non-small-cell lung cancer— a Canadian experience Abstract   PDF   HTML
D. A. Ezeife, B. Melosky, R. Tudor, S. Lin, A. Lau, T. Panzarella, N. B. Leighl
 
Vol 21, No 1 (2014) Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis Abstract   PDF   HTML
I. Kong, S.A. Narod, C. Taylor, L. Paszat, R. Saskin, S. Nofech-Moses, D. Thiruchelvam, W. Hanna, J.P. Pignol, S. Sengupta, L. Elavathil, P.A. Jani, S.J. Done, S. Metcalfe, E. Rakovitch
 
Vol 25, No 1 (2018) Alberta CancerBridges development of a care plan evaluation measure Abstract   PDF   HTML
J. Giese-Davis, J. Sisler, L. Zhong, Y. Brandelli, J.L. McCormick, C. Railton, L. Shirt, H. Lau, D. Hao, J. Chobanuk, B. Walley, A.A. Joy, A. Taylor, L. Carlson
 
Vol 14, No 3 (2007) Alemtuzumab in Chronic Lymphocytic Leukemia: A Systematic Review and Clinical Practice Guideline Details   PDF
Christopher A Smith
 
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Algorithm for the treatment of advanced or metastatic squamous non-small-cell lung cancer: an evidence-based overview Abstract   PDF   HTML
N. Daaboul, G. Nicholas, S. A. Laurie
 
Vol 20, No 1 (2013) Alignment of practice guidelines with targeted-therapy drug funding policies in Ontario Abstract   PDF   HTML
R. Ramjeesingh, R.M. Meyer, M. Brouwers, B.E. Chen, C.M. Booth
 
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist ALK inhibitors, resistance development, clinical trials Abstract   PDF   HTML
J.M. Rothenstein, N. Chooback
 
Vol 20, No 4 (2013) Aloe vera for prevention of radiation-induced dermatitis: a self-controlled clinical trial Abstract   PDF   HTML
P. Haddad, F. Amouzgar-Hashemi, S. Samsami, S. Chinichian, M.A. Oghabian
 
Vol 19, No 2 (2012) Alternative and orthodox medicine and the “odd” principle Abstract   PDF   HTML
L.Z.G. Touyz
 
Vol 18, No 2 (2011) An appraisal of life’s terminal phases and euthanasia and the right to die Details   PDF   HTML
L. Z.G. Touyz, S. J.J. Touyz
 
Vol 15, No 2 (2008) An Approach to the Management of Chronic Myeloid Leukemia in British Columbia Details   PDF
Donna Lynn Forrest, X Jiang, C Eaves, C Smith
 
Vol 24, No 6 (2017) An evaluation of the behaviour-change techniques used on Canadian cancer centre Web sites to support physical activity behaviour for breast cancer survivors Abstract   PDF   HTML
B.D. Sylvester, K. Zammit, A.J. Fong, C.M. Sabiston
 
Vol 26, No 4 (2019) An evaluation of the safety of continuing trastuzumab despite overt left ventricular dysfunction Abstract   PDF   HTML
C. C. Barron, M.M. Alhussein, U. Kaur, T. L. Cosman, N. Kumar Tyagi, M. Brown, S. D. Mukherjee, P. M. Ellis, S. Dhesy-Thind, D. P. Leong
 
Vol 22, No 3 (2015) An exploratory comparative analysis of tyrosine kinase inhibitors or docetaxel in second-line treatment of EGFR wild-type non-small-cell lung cancer: a retrospective real-world practice review at a single tertiary care centre Abstract   PDF   HTML
K. Ma, V. Cohen, G. Kasymjanova, D. Small, K. Novac, J. Peterson, A. Levitt, J. Agulnik
 
Vol 26, No 3 (2019) An integrated knowledge translation approach to develop a shared decision-making strategy for use by Inuit in cancer care: a qualitative study Abstract   PDF   HTML
J. Jull, A. Hizaka, A. J. Sheppard, A. Kewayosh, P. Doering, L. MacLeod, G. Joudain, J. Plourde, D. Dorschner, The Inuit Medical Interpreter Team, M. Rand, M. Habash, I. D. Graham
 
Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective AN INTEGRATED SUPPORT AND INFORMATION CENTRE IN A LARGE UK CANCER CENTRE ESTABLISHED IN 1993 & REPLICATED IN MORE THAN 60 UNITS ACROSS THE UK AND AUSTRALIA. Abstract   PDF
Jane Maher
 
Vol 22, No 3 (2015) An intermediate step for the management of hypersensitivity to platinum and taxane chemotherapy Abstract   PDF   HTML
M. Bahl, T. Dean
 
Vol 20, No 6 (2013) An interprofessional palliative care oncology rehabilitation program: effects on function and predictors of program completion Abstract   PDF   HTML
M.R. Chasen, A. Feldstain, D. Gravelle, N. MacDonald, J. Pereira
 
Vol 22, No 4 (2015) An open-label expanded-access trial of bendamustine in patients with rituximab-refractory indolent non-Hodgkin lymphoma or previously untreated chronic lymphocytic leukemia: BEND-ACT Abstract   PDF   HTML
C.T. Kouroukis, M. Crump, D. MacDonald, J.F. Larouche, D.A. Stewart, J. Johnston, S. Sauvageau, E. Beausoleil, P. Sage, S.G. Dubois, A. Christofides, S. Di Clemente, L. Sehn
 
Vol 16 (2009): Endocrine Therapy Update Supplement An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor–positive early breast cancer Abstract   PDF
S. Verma, S. Sehdev, A Joy, Y. Madarnas, J. Younus, J. A. Roy
 
Vol 15, No 5 (2008) Anal Cancer and Human Papillomaviruses in Heterosexual Men Abstract   PDF
Alan Nyitray
 
Vol 20, No 2 (2013) Analysis of intraprostatic therapeutic effects in prostate cancer patients using [11C]-choline PET/CT after external-beam radiation therapy Abstract   PDF   HTML
J. Amanie, H.S. Jans, M. Wuest, N. Pervez, A. Murtha, N. Usmani, D. Yee, R. Pearcey, B. Danielson, S. Patel, R. Macewan, C. Field, D. Robinson, J. Wilson, D. Lewis, M. Parliament, A.J.B. McEwan
 
Vol 22, No 6 (2015) Analysis of liver-directed therapies in U.S. cancer patients Abstract   PDF   HTML
O.B. Alese, S. Kim, Z. Chen, S.S. Ramalingam, T.K. Owonikoko, B.F. El-Rayes
 
Vol 22, No 2 (2015) Analysis of sebum lipid composition and the development of acneiform rash before and after administration of egfr inhibitor Abstract   PDF   HTML
T. Nakahara, Y. Moroi, K. Takayama, Y. Nakanishi, M. Furue
 
Vol 25, No 3 (2018) Anastomosing hemangioma of the kidney: radiologic and pathologic distinctions of a kidney cancer mimic Abstract   PDF   HTML
P.M. Cheon, R. Rebello, A. Naqvi, S. Popovic, M. Bonert, A. Kapoor
 
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective Androgen deprivation therapy for prostate cancer—review of indications in 2010 Abstract   PDF
H. Quon, D.A. Loblaw
 
Vol 19 (2012): Improving Patient Outcomes in Advanced Prostate Cancer Androgen deprivation therapy in advanced prostate cancer: is intermittent therapy the new standard of care? Abstract   PDF   HTML
L. Klotz, P. Toren
 
Vol 14, No 6 (2007) Anemia is a common but neglected complication of adjuvant chemotherapy for early-stage breast cancer Details   PDF
Amanda Goldrick, Ivo A Olivotto, Cheryl Alexander, Caroline H Speers, Jeff Barnett, Sharon J Allan, Pauline T Truong
 
Vol 23, No 6 (2016) Annual surveillance mammography after early-stage breast cancer and breast cancer mortality Abstract   PDF   HTML
L.E. Paszat, R. Sutradhar, S. Gu, E. Rakovitch
 
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Antiangiogenic therapies in non-small-cell lung cancer Abstract   PDF   HTML
A. Alshangiti, G. Chandhoke, P.M. Ellis
 
Vol 21, No 1 (2014) Anticancer activity of combination targeted therapy using cetuximab plus vemurafenib for refractory BRAFV600E-mutant metastatic colorectal carcinoma Abstract   PDF   HTML
K. Connolly, D. Brungs, E. Szeto, R.J. Epstein
 
Vol 23 (2016): Use of Cannabinoids in Cancer Care Anticancer mechanisms of cannabinoids Abstract   PDF   HTML
G. Velasco, C. Sánchez, M. Guzmán
 
Vol 25, No 6 (2018) Anti-Yo antibody–mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review Abstract   PDF   HTML
M. Le May, S. Dent
 
Vol 17, No 4 (2010) Aplastic anemia with concurrent temozolomide treatment in a patient with glioblastoma multiforme Abstract   PDF
J. Oh, G.J. Kutas, P. Davey, M. Morrison, J.R. Perry
 
Vol 17, No 1 (2010) Application of machine learning methodology for PET-based definition of lung cancer Abstract   PDF
A. Kerhet, C. Small, H. Quon, T. Riauka, L. Schrader, R. Greiner, D. Yee, A. McEwan, W. Roa
 
Vol 23, No 3 (2016) Approach to biomarker testing: perspectives from various specialties Abstract   PDF   HTML
M.R. Sung, P.M. Ellis, S. Verma, E. Duncan, N.B. Leighl
 
Vol 23, No 4 (2016) Approach to fever assessment in ambulatory cancer patients receiving chemotherapy: a clinical practice guideline Abstract   PDF   HTML
M.K. Krzyzanowska, C. Walker-Dilks, C. Atzema, A. Morris, R. Gupta, R. Halligan, T. Kouroukis, K. McCann
 
Vol 25, No 6 (2018) Appropriate treatment receipt after breast-conserving surgery Abstract   PDF   Supplemental Material   HTML
K. Guidolin, M. Lock, K. Vogt, J. A. McClure, J. Winick-Ng, C. Vinden, M. Brackstone
 
Vol 21, No 6 (2014) Aprepitant and granisetron for the prophylaxis of radiotherapy-induced nausea and vomiting after moderately emetogenic radiotherapy for bone metastases: a prospective pilot study Abstract   PDF   HTML
K. Dennis, C. De Angelis, F. Jon, N. Lauzon, M. Pasetka, L. Holden, E. Barnes, C. Danjoux, A. Sahgal, M. Tsao, E. Chow
 
Vol 19, No 5 (2012) Are bilateral cancers hereditary? Part II Details   PDF   HTML
S. Narod
 
Vol 25, No 4 (2018) Are clinical trial eligibility criteria an accurate reflection of a real-world population of advanced non-small-cell lung cancer patients? Abstract   PDF   HTML
K. Al-Baimani, H. Jonker, T. Zhang, G.D. Goss, S.A. Laurie, G. Nicholas, P. Wheatley-Price
 
Vol 15, No 4 (2008) Are Matrix Metalloproteinases Relevant Therapeutic Targets for Prostate Cancer Bone Metastasis? Abstract   PDF
R. Daniel Bonfil, Rafael Fridman, Shahriar Mobashery, Michael L. Cher
 
Vol 26, No 2 (2019) Are patient education materials about cancer screening more effective when co-created with patients? A qualitative interview study and randomized controlled trial Abstract   PDF   HTML
N. Y. Bashir, J. E. Moore, D. Buckland, M. Rodrigues, M. Tonelli, B. D. Thombs, N. R. Bell, W. Isaranuwatchai, T. Peng, D. M. Shilman, S. E. Straus
 
Vol 25, No 5 (2018) Are patient-reported outcomes of physical function a valid substitute for objective measurements? Abstract   PDF   HTML
J. A.J. Douma, H. M.W. Verheul, L. M. Buffart
 
Vol 22, No 5 (2015) Are patients receiving the right care in the right place at the right time? Abstract   PDF   HTML
M. Chasen, N. Dosani
 
Vol 20, No 4 (2013) Are two-centimeter breast cancers large or small? Abstract   PDF   HTML
S.A. Narod, J. Iqbal, A. Jakubowska, T. Huzarski, P. Sun, C. Cybulski, J. Gronwald, T. Byrski, J. Lubinski
 
Vol 26 (2019): Advances in Colorectal Cancer: Translating Best Evidence to Practice Are we finally moving toward personalized therapy in colorectal cancer? Abstract   PDF   HTML
S. Gill
 
Vol 26, No 2 (2019) Area-level income disparities in colorectal screening in Canada: evidence to inform future surveillance Abstract   PDF   HTML   Supplemental Material
A. Blair, L. Gauvin, S. Ouédraogo, G. D. Datta
 
Vol 25, No 2 (2018) Aromatase inhibitors in premenopausal women with breast cancer: the state of the art and future prospects Abstract   PDF   HTML
M. Pistelli, A. Della Mora, Z. Ballatore, R. Berardi
 
Vol 18, No 5 (2011) Array comparative genomic hybridization and cytogenetic analysis in pediatric acute leukemias Abstract   PDF   HTML
A. J. Dawson, R. Yanofsky, R. Vallente, S. Bal, I. Schroedter, L. Liang, S. Mai
 
Vol 17, No 6 (2010) Arterial embolization for ruptured adrenal pheochromocytoma Abstract   PDF
M. Habib, I. Tarazi, M. Batta
 
Vol 17, No 6 (2010) Arterial occlusion precipitated by cisplatin-based chemotherapy Abstract   PDF
D. Joseph, B. Dubashi, B. Karthikeyan, A. Jain
 
Vol 24, No 4 (2017) ASCO 2017 meeting summary: updates to practice-changing studies in untreated non-Hodgkin lymphoma Abstract   PDF   HTML
P. Laneuville, J.F. Larouche, A. Tosikyan, A. Christofides
 
Vol 20, No 2 (2013) Assessing fitness to drive in brain tumour patients: a grey matter of law, ethics, and medicine Abstract   PDF   HTML
A.V. Louie, E. Chan, M. Hanna, G.S. Bauman, B.J. Fisher, D.A. Palma, G.B. Rodrigues, A. Warner, D.P. D'Souza
 
Vol 25, No 1 (2018) Assessing post-radiotherapy handover notes from a family physician perspective Abstract   PDF   HTML   Supplemental Materials
A. Dang, S. Miller, D. Horvat, T. Klassen-Ross, M. Graveline, R. Collins, R. Olson
 
Vol 26, No 3 (2019) Assessing the impact of mailing self-sampling kits for human papillomavirus testing to unscreened non-responder women in Manitoba Abstract   PDF   HTML
F. Jalili, C. O'Conaill, K. Templeton, R. Lotocki, G. Fischer, L. Manning, K. Cormier, K. Decker
 
Vol 18, No 6 (2011) Assessment and management of febrile neutropenia in emergency departments within a regional health authority—a benchmark analysis Abstract   PDF   HTML
D. Szwajcer, P. Czaykowski, D. Turner
 
Vol 19, No 3 (2012) Assisted death and the slippery slope—finding clarity amid advocacy, convergence, and complexity Abstract   PDF   HTML
M.J. Shariff
 
Vol 23, No 5 (2016) Association between basal-like phenotype and BRCA1/2 germline mutations in Korean breast cancer patients Abstract   PDF   HTML
J. Jung, E. Kang, J.M. Gwak, A.N. Seo, S.Y. Park, A.S. Lee, H. Baek, S. Chae, E.K. Kim, S.W. Kim
 
Vol 17, No 5 (2010) Association of lipid metabolism with ovarian cancer Abstract   PDF
M. Tania, M.A. Khan, Y. Song
 
Vol 26, No 3 (2019) Association of preoperative anemia and perioperative allogenic red blood cell transfusion with oncologic outcomes in patients with nonmetastatic colorectal cancer Abstract   PDF   HTML   Supplemental Material
H. Y. Kwon, B. R. Kim, Y. W. Kim
 
Vol 23, No 3 (2016) Astragalus-containing Traditional Chinese Medicine, with and without prescription based on syndrome differentiation, combined with chemotherapy for advanced non-small-cell lung cancer: a systemic review and meta-analysis Abstract   PDF   HTML
S.F. Wang, Q. Wang, L.J. Jiao, Y.L. Huang, D. Garfield, J. Zhang, L. Xu
 
Vol 25, No 2 (2018) Ataxia–telangiectasia gene (ATM) mutation heterozygosity in breast cancer: a narrative review Abstract   PDF   HTML
K.J. Jerzak, T. Mancuso, A. Eisen
 
Vol 18, No 6 (2011) Author Index Abstract   PDF   HTML
Current Oncology
 
Vol 19, No 6 (2012) Author Index Details   PDF   HTML
Current Oncology
 
Vol 20, No 6 (2013) Author Index Details   PDF   HTML
Various Authors
 
Vol 21, No 6 (2014) Author Index Abstract   PDF   HTML
Various Authors
 
Vol 13, No 1 (2006) Awareness and Use of the Rapid Palliative Radiotherapy Program by Family Physicians in Eastern Ontario: A Survey Details   PDF
E J Fitzgibbon
 
Vol 20, No 3 (2013) Axillary lymph node status, adjusted for pathologic complete response in breast and axilla after neoadjuvant chemotherapy, predicts differential disease-free survival in breast cancer Abstract   PDF   HTML
G.C. Zhang, Y.F. Zhang, F.P. Xu, X.K. Qian, Z.B. Guo, C.Y. Ren, M. Yao
 
Vol 25, No 1 (2018) Azacitidine-induced pyoderma gangrenosum at injection sites in a patient with myelodysplastic syndrome Abstract   PDF   HTML
C. Roy, J.P. Adam, F. Morin, É. Lemieux-Blanchard, S. Doucet, D. Friedmann, A. Belisle, D. Charpentier
 
Vol 17, No 3 (2010) Balancing potential quality-of-life benefits against the risk of lethal late recurrence with bladder-preserving surgery Abstract   PDF
L. Klotz
 
Vol 25, No 2 (2018) Barriers to participation in clinical trials: a physician survey Abstract   PDF   HTML
A. Mahmud, O. Zalay, A. Springer, K. Arts, E. Eisenhauer
 
Vol 25, No 4 (2018) Baseline Edmonton Symptom Assessment System and survival in metastatic renal cell carcinoma Abstract   PDF   HTML
J. Graham, J. Gingerich, P. Lambert, A. Alamri, P. Czaykowski
 
Vol 20, No 5 (2013) Benefits, issues, and recommendations for personalized medicine in oncology in Canada Abstract   PDF   HTML
C. Butts, S. Kamel–Reid, G. Batist, S. Chia, C. Blanke, M. Moore, M.B. Sawyer, C.C. Desjardins, A. Dubois, J. Pun, K. Bonter, Fredrick D Ashbury
 
Vol 17, No 5 (2010) Bevacizumab in combination with FOLFIRI chemotherapy in patients with metastatic colorectal cancer: an assessment of safety and efficacy in the province of Newfoundland and Labrador Abstract   PDF
G. Dranitsaris, S. Edwards, J. Edwards, M. Leblanc, R. Abbott
 
Vol 20, No 5 (2013) Bevacizumab-based therapy for colorectal cancer: experience from a large Canadian cohort at the Jewish General Hospital between 2004 and 2009 Abstract   PDF   HTML
N. Bouganim, A. Mamo, D.W. Wasserman, G. Batist, P. Metrakos, P. Chaudhury, M. Hassanain, P. Kavan
 
Vol 22, No 3 (2015) Beyond the mammography debate: a moderate perspective Abstract   PDF   HTML
C. Kaniklidis
 
Vol 21, No 1 (2014) Bilineal T lymphoblastic and myeloid blast transformation in chronic myeloid leukemia with TP53 mutation—an uncommon presentation in adults Abstract   PDF   HTML
S. Krishnan, K. Sabai, C. Chuah, S.Y. Tan
 
Vol 15, No 2 (2008) Biochemotherapy for the Treatment of Metastatic Malignant Melanoma: A Clinical Practice Guideline Abstract   PDF
Denise Stys-Norman
 
Vol 23, No 5 (2016) Bioelectrical impedance phase angle as a prognostic indicator of survival in head-and-neck cancer Abstract   PDF   HTML
M.S. Wladysiuk, R. Mlak, K. Morshed, W. Surtel, A. Brzozowska, T. Małecka-Massalska
 
Vol 21, No 4 (2014) Biologic, psychological, and social health needs in cancer care: how far have we come? Abstract   PDF   HTML
F. Schulte
 
Vol 13, No 1 (2006) Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma Details   PDF
Lara J Williams, Duane L Guernsey, Alan G Casson
 
Vol 19 (2012): Personalized Medicine in Metastatic NSCLC: a Canadian Perspective Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRAS Abstract   PDF   HTML
M.D. Vincent, M.S. Kuruvilla, N.B. Leighl, S. Kamel-Reid
 
Vol 16, No 6 (2009) Bogarting that joint might decrease oral HPV among cannabis users Abstract   PDF
S. Zwenger
 
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective Bone health in nonmetastatic prostate cancer: what’s the big deal? Abstract   PDF
J.B. Lattouf, F. Saad
 
101 - 200 of 1685 Items << < 1 2 3 4 5 6 7 8 9 10 > >>